Grant

An International, Randomized, Double-Blink, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients - CDX110-04

Sponsored by Celldex Therapeutics, Incorporated

$325.2K Funding

1 People

External

Related Topics

clinical trials, immunotherapy, oncology, temozolomide, cancer treatment

People

Baldassarre Stea
Principal Investigator (PI)
Radiation Oncology﹒Department Head